TITLE

Improve project management by following best practices

PUB. DATE
April 2007
SOURCE
Clinical Trials Administrator;Apr2007, Vol. 5 Issue 4, p46
SOURCE TYPE
Periodical
DOC. TYPE
Article
ABSTRACT
The article discusses how practices can enhance medical project management. Joanne M. Chilton of SUNY Upstate Medical University in New York stressed that the background of a study and patient population should be acquired when receiving a call from a pharmaceutical company for a clinical trial. She suggested imposing a facility fee and standard prices. She stated that a consistent monitor should be selected to have good relationship with the site monitor after the clinical trial agreement.
ACCESSION #
24690617

 

Related Articles

  • Project Management and CMO-Sponsor Relations. Lueken, Sandra // Pharmaceutical Technology;Aug2007 Supplement, Vol. 31, p34 

    Shrinking budgets and shortened timelines have kd to an increase in pharmaceutical outsourcing. Contract manufacturing organizations and sponsor companies must work together to meet stringent timelines for delivering products for clinical trials and commercial use while companying with...

  • Smart Outsourcing: Strategic Alignment, Risk Management, and New Relationships. Schmit, Willam; Uydess, Ian // BioPharm International;Mar2012 Supplement, ps35 

    The article offers information on the smart outsourcing in pharmaceutical industry. It says that pharmaceutical's outsourcing is being confined to clinical trial support, drug packaging, and commercial manufacturing. It mentions several business and operational benefits of smart outsourcing,...

  • CRO Quality Benchmarking.  // Applied Clinical Trials;Aug/Sep2015, Vol. 24 Issue 8/9, p6 

    The article presents a diagram, which depict statistics related to formal preferred provider agreements of pharmaceutical companies regarding phase II and III level clinical trials.

  • The tribulations of community-based trials.  // CMAJ: Canadian Medical Association Journal;1/6/2004, Vol. 170 Issue 1, p33 

    Focuses on the trend of clinical trials sponsored by the pharmaceutical industry in Canada migrating from academic settings into the community. Challenges posed to physicians and the medical profession; Impact on issues of conflict of interest, patient safety and public interest; Percentage of...

  • Working the Pharmaceutical PIPELINE Databases. Breton, Tara // Searcher;Sep2003, Vol. 11 Issue 8, p32 

    Presents information on how to use a pharmaceutical pipeline database. Definition of a pipeline; Levels of a pharmaceutical pipeline; Information on the actual pipeline process.

  • Optimizing Phase III Trials. McLennan, Derek; Foley, Patrick // European Pharmaceutical Executive;Feb/Mar2007, p40 

    The article discusses some of the pitfalls inherent in the Phase III planning process and proposes some solutions for getting it right. The authors suggests that developing successful Phase III clinical trial strategies in today's European pharmaceutical marketing environment requires a balance...

  • Nanclinical Development Becoming a Big Business. Miller, Jim // BioPharm International;Jul2006, Vol. 19 Issue 7, p30 

    The article focuses on the nonclinical research business in which companies are pursuing the integrated supply chain model offering clients an accelerated part from benchtop to clinic. The author points out that the clinical research business is much harder to consolidate that the contract...

  • Outsourcing can control spiralling R&D.  // Pharmaceutical Technology Europe;Sep2004 Supplement, Vol. 16, p9 

    This article presents information on pharmaceutical outsourcing. Companies developing new drugs must deal with the rising costs of research and development, and outsourcing may well be the best route. That is the verdict of Faiz Kermani of Chiltern International, who adds that the problem stems...

  • Virtual Discovery & Development. McGee, Patrick // Drug Discovery & Development;Jun2005, Vol. 8 Issue 6, p26 

    The article presents a profile of TAP Pharmaceutical Products inc., which has adopted outsourcing as its new business model. TAP owns no laboratories, relies almost entirely on licenses and contract agreements, and functions almost like a virtual company. It outsources nearly all elements of the...

Share

Read the Article

Courtesy of VIRGINIA BEACH PUBLIC LIBRARY AND SYSTEM

Sorry, but this item is not currently available from your library.

Try another library?
Sign out of this library

Other Topics